A multi-center prospective study of re-irradiation with bevacizumab and temozolomide in patients with bevacizumab refractory recurrent high-grade gliomas.
J Neurooncol
; 155(3): 297-306, 2021 Dec.
Article
in En
| MEDLINE
| ID: mdl-34689306
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Brain Neoplasms
/
Chemoradiotherapy
/
Re-Irradiation
/
Glioma
Type of study:
Clinical_trials
/
Observational_studies
Limits:
Humans
Language:
En
Journal:
J Neurooncol
Year:
2021
Type:
Article
Affiliation country:
United States